Phase I trial of sublingual apomorphine in patients with Parkinson's disease.
Phase of Trial: Phase II
Latest Information Update: 27 Jun 2011
At a glance
- Drugs Apomorphine (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- Sponsors Amarin Corporation
- 27 Jun 2011 Status changed from planning to discontinued prior to enrolment.
- 26 Nov 2007 New trial record.